We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

0A4X Adamis Pharmaceuticals Corp

0.00 (0.00%)

Adamis Pharmaceuticals Financial Summary

The current 0A4X market cap is 0. The company's latest EPS is USD -2.6211 and P/E is -0.09.

Year End 31 December 2022 20182019202020212022
Total Revenue 15.09M22.11M16.53M2.21M4.76M
Operating Income -39.46M-29.03M-46.91M-32.07M-25.06M
Net Income -39.01M-29.31M-49.39M-45.83M-26.48M
Year End 31 December 2022 20182019202020212022
Total Assets 58.36M47.84M30.87M38.3M10.93M
Total Liabilities 11.67M11.8M27.37M12.42M11.58M
Total Equity 46.69M36.04M3.5M25.88M-808k

Cash Flow

Year End 31 December 2022 20182019202020212022
Operating -32.66M-19.89M-20.9M-37.79M-25.9M
Investing -3.54M-2.87M-946k283k3.48M
Financing 37.13M12.29M19.89M53.94M285k
Market Cap 0
Price to Earnings Ratio -0.09
Price to Sales Ratio 0.49
Price to Cash Ratio 2.15
Price to Book Ratio -3.57
Dividend Yield -

Share Statistics

Shares Outstanding 10.1M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0 (0%)

Company Info

Company Name Adamis Pharmaceuticals Corp
Address 251 little falls drive
wilmington, delaware 19808
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |